AKT1 and cancer: Collectively, these findings of the current study suggest that the downregulation in the phosphorylation levels of c-Met and its downstream signaling kinases Akt, Src and p38 MAPK by E7050 can result in the inhibition of multidrug-resistant cancer cell growth, proliferation and survival (Figure 8).